Market Overview:
The global human milk oligosaccharides (HMO) market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising awareness about the benefits of HMOs, increasing demand for infant formula and other applications, and growing research and development activities. The global human milk oligosaccharides (HMO) market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 2'-FL & 3-FL, sialyllactose, LNT & LNnT. On the basis of application, the market is segmented into infant formula, functional food & beverages, food/medical supplements, and other applications.
 Industry Outlook.svg)
Product Definition:
Human milk oligosaccharides (HMO) are a type of prebiotic. They are a special type of carbohydrate that is not digestible by humans, but is instead broken down by bacteria in the gut. HMOs provide important nutrients for the growth and development of gut bacteria, which can have positive health effects for both infants and adults.
2'-FL & 3-FL:
2-fluorodeoxyglucose (2'-FL) and 3-fluorodeoxyglucose (3'-FL) are the two forms of FLNA, a human milk oligosaccharide. It is an important component of human milk that helps in providing protection against bacterial infection. The growth factor for 2' - FL & 3 ' - FL in HMO market is Human Milk Oligosaccharides (HMO).
Sialyllactose:
Sialyllactose is a type of oligosaccharide that is found in the human milk. It can be extracted from human milk and used as an alternative to HMO in infant formulas. The demand for sialyllactose has been increasing due to its ability to provide similar nutritional benefits as compared to traditional Human Milk Oligosaccharides (HMO).
Application Insights:
On the basis of application, the global human milk oligosaccharides (HMO) market has been segmented into infant formula, functional food & beverages, food/medical supplements and other applications. Infant formula was estimated as the largest segment in 2017 owing to increasing demand for HMO-based products in this sector. The use of HMOs promotes healthy growth and development of infants by improving their gut health and preventing lactose digestion problems. These medium chain carbohydrates are also considered beneficial for mothers due to improved nutrient absorption during breastfeeding.
Functional foods & beverages is expected to be one of the fastest growing segments over the forecast period owing to rising consumer awareness regarding maintaining a balanced diet along with exercise and proper nutrition habits. Maintaining a healthy lifestyle helps prevent several diseases including cardiovascular diseases, cancer cells proliferation etc., which is likely to propel product demand in this application segment over next few years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period owing to high demand for human milk oligosaccharides from countries, such as U.S., Canada, and Mexico.
Asia Pacific is expected to be one of fastest-growing regions during the forecast years due to rising disposable income coupled with growing population especially in China.
Growth Factors:
- Increasing awareness about the benefits of human milk oligosaccharides for infants is expected to drive the market growth.
- Rising demand for infant formula products fortified with HMOs is anticipated to propel the market growth.
- Growing number of research studies on the health benefits of HMOs is projected to fuel market demand in the coming years.
- Increasing adoption of breastfeeding as a mode of infant feeding is likely to boost demand for human milk oligosaccharides over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Milk Oligosaccharides (HMO) Market Research Report
By Type
2'-FL & 3-FL, Sialyllactose, LNT & LNnT
By Application
Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Other
By Companies
Abbott, Inbiose, Elicityl SA, Jennewein Biotechnologie, ZuChem, Dextra Laboratories, Glycom
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Human Milk Oligosaccharides (HMO) Market Report Segments:
The global Human Milk Oligosaccharides (HMO) market is segmented on the basis of:
Types
2'-FL & 3-FL, Sialyllactose, LNT & LNnT
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infant Formula, Functional Food & Beverages, Food/Medical Supplements, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Inbiose
- Elicityl SA
- Jennewein Biotechnologie
- ZuChem
- Dextra Laboratories
- Glycom
 Market Overview.svg)
Highlights of The Human Milk Oligosaccharides (HMO) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2'-FL & 3-FL
- Sialyllactose
- LNT & LNnT
- By Application:
- Infant Formula
- Functional Food & Beverages
- Food/Medical Supplements
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Milk Oligosaccharides (HMO) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human milk oligosaccharides are complex carbohydrates that are found in human milk. These carbohydrates help to provide energy for the baby while breastfeeding.
Some of the major players in the human milk oligosaccharides (hmo) market are Abbott, Inbiose, Elicityl SA, Jennewein Biotechnologie, ZuChem, Dextra Laboratories, Glycom.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Human Milk Oligosaccharides (HMO) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Human Milk Oligosaccharides (HMO) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Human Milk Oligosaccharides (HMO) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Human Milk Oligosaccharides (HMO) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Human Milk Oligosaccharides (HMO) Market Size & Forecast, 2020-2028
4.5.1 Human Milk Oligosaccharides (HMO) Market Size and Y-o-Y Growth
4.5.2 Human Milk Oligosaccharides (HMO) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2'-FL & 3-FL
5.2.2 Sialyllactose
5.2.3 LNT & LNnT
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Infant Formula
6.2.2 Functional Food & Beverages
6.2.3 Food/Medical Supplements
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Human Milk Oligosaccharides (HMO) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Human Milk Oligosaccharides (HMO) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2'-FL & 3-FL
9.6.2 Sialyllactose
9.6.3 LNT & LNnT
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Infant Formula
9.10.2 Functional Food & Beverages
9.10.3 Food/Medical Supplements
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2'-FL & 3-FL
10.6.2 Sialyllactose
10.6.3 LNT & LNnT
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Infant Formula
10.10.2 Functional Food & Beverages
10.10.3 Food/Medical Supplements
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2'-FL & 3-FL
11.6.2 Sialyllactose
11.6.3 LNT & LNnT
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Infant Formula
11.10.2 Functional Food & Beverages
11.10.3 Food/Medical Supplements
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2'-FL & 3-FL
12.6.2 Sialyllactose
12.6.3 LNT & LNnT
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Infant Formula
12.10.2 Functional Food & Beverages
12.10.3 Food/Medical Supplements
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2'-FL & 3-FL
13.6.2 Sialyllactose
13.6.3 LNT & LNnT
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Infant Formula
13.10.2 Functional Food & Beverages
13.10.3 Food/Medical Supplements
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Human Milk Oligosaccharides (HMO) Market: Competitive Dashboard
14.2 Global Human Milk Oligosaccharides (HMO) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Inbiose
14.3.3 Elicityl SA
14.3.4 Jennewein Biotechnologie
14.3.5 ZuChem
14.3.6 Dextra Laboratories
14.3.7 Glycom
